InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Blasticidin | Lamina-associated polypeptide 2α is required for intranuclear MRTF-A activity. | 2022 | Sci Rep | Sidorenko E. et al. | DOI: 10.1038/s41598-022-06135-5 |
Puromycin | CRISPR and biochemical screens identify MAZ as a cofactor in CTCF-mediated in... | 2022 | Nat Genet | Ortabozkoyun H. et al. | DOI: 10.1038/s41588-021-01008-5 |
Blasticidin | CRISPR and biochemical screens identify MAZ as a cofactor in CTCF-mediated in... | 2022 | Nat Genet | Ortabozkoyun H. et al. | DOI: 10.1038/s41588-021-01008-5 |
Primocin® | Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell... | 2022 | Theranostics | Teijeira A. et al. | DOI: 10.7150/thno.63359 |
Primocin® | Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinan... | 2022 | Eng Life Sci | Verbelen B. et al. | DOI: 10.1002/elsc.202100124 |
Puromycin | Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient ... | 2022 | Mol Ther Nucleic Acids | Baron Y. et al. | DOI: 10.1016/j.omtn.2021.12.033 |
Peptide M / Agarose | Saliva as a useful tool for evaluating upper mucosal antibody response to inf... | 2022 | PLoS One | Tsunetsugu-Yokota Y. et al. | DOI: 10.1371/journal.pone.0263419 |
Human TLR5 Reporter HEK293 Cells (NF-κB) | Compensatory intestinal antibody response against pro-inflammatory microbiota... | 2022 | Gut Microbes | Scheithauer T.P.M et al. | DOI: 10.1080/19490976.2022.2031696 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Compensatory intestinal antibody response against pro-inflammatory microbiota... | 2022 | Gut Microbes | Scheithauer T.P.M et al. | DOI: 10.1080/19490976.2022.2031696 |
HEK-Blue™ Detection | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
Human TLR2 and TLR6 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
LPS-EK (LPS from E. coli K12) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
Human TLR2 and TLR1 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Pilus proteins from Streptococcus pyogenes stimulate innate immune responses ... | 2022 | Immunol Cell Biol | Takahashi R. et al. | DOI: 10.1111/imcb.12523 |
Puromycin | Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induc... | 2022 | Biochem J. | Chihara K. et al. | DOI: 10.1042/BCJ20210707 |
TDB | Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induc... | 2022 | Biochem J. | Chihara K. et al. | DOI: 10.1042/BCJ20210707 |
Poly(I:C) LMW | Interferon-γ primes macrophages for pathogen ligand-induced killing via a cas... | 2022 | Immunity | Simpson D.S. et al. | DOI: 10.1016/j.immuni.2022.01.003 |
LPS-EB (LPS from E. coli O111:B4) | Interferon-γ primes macrophages for pathogen ligand-induced killing via a cas... | 2022 | Immunity | Simpson D.S. et al. | DOI: 10.1016/j.immuni.2022.01.003 |
Poly(I:C) HMW | Interferon-γ primes macrophages for pathogen ligand-induced killing via a cas... | 2022 | Immunity | Simpson D.S. et al. | DOI: 10.1016/j.immuni.2022.01.003 |